Women_s Groups Demand Egg Donation Probe
By The Chosun Ilbo,
The Chosun Ilbo
| 01. 04. 2006
Korea_s already battered biotech industry faces a fresh challenge from women_s rights activists angry at what they see as a high-handed approach to occyte procurement for cloning and other embryonic research. Some 30 women_s rights groups including Korea Women's Associations United (KWAU) on Wednesday urged authorities to investigate egg cell procurement for experiments by the disgraced cloning researcher Hwang Woo-suk. The groups made the call in a press conference at the Seoul Press Center.
The activists said the government was so dazzled by the profits it expected stem cell technology to net the nation that it became blind to the danger to women_s life and health from donating eggs. They said there was an urgent need to discover how many eggs from how many donors were used in Hwang_s experiments, what motivated the donors, how the eggs were extracted, and what institutions were involved. They also called for an investigation of whether two junior researchers in Hwang_s team were pressured to donate their own eggs, and demanded that the government compensate donors for any damage to their health from the...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...